AC Immune’s Mixed Phase II Results Buoy Alzheimer’s Research
An Alzheimer’s disease drug developed by AC Immune and Genentech has drawn conflicting phase II…
September 2, 2021 - 5 minutes
AC Immune
A Year to Remember: The Biggest European Biotech News in 2020
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
December 28, 2020 - 12 minutes
Eli Lilly Sweetens AC Immune Alzheimer’s Treatment Deal by €38M
A deal between Swiss biotech AC Immune and Eli Lilly to develop an oral Alzheimer’s…
March 24, 2020 - 3 minutes
AC Immune Gets €28M from Eli Lilly as Alzheimer’s Drug Hits Phase I
AC Immune will receive €27.6M (CHF 30M) from big pharma Eli Lilly as it begins…
September 23, 2019 - 2 minutes
The Top 20 Women in Leading Biotech Roles in Europe
The biotech industry has often been criticized for its lack of gender diversity. While there…
May 21, 2019 - 12 minutes
Top 10 Biotechs in Lausanne
The Swiss city of Lausanne is perhaps best known as a hub of international sport,…
May 8, 2019 - 7 minutes
Say Hello to the Top 14 Entrepreneurial Women in European Biotech
Today, March 8, is international women's day. To celebrate the achievements of women we're revisiting…
March 8, 2018 - 8 minutes
Happy 2018, Here Are the Top 9 European Biotech Companies To Watch
As the 2017 reports roll in, we're already turning our gaze to 2018. These are…
January 9, 2018 - 5 minutes
Meet the Swiss CEO Pulling Out All the Stops Against Alzheimer’s Disease
Efforts to treat Alzheimer’s Disease have been hit with failure after failure in the last…
January 8, 2018 - 8 minutes
Swiss Biotech Gets €12M as its Alzheimer’s Candidate Enters Phase II
AC Immune's Anti-Tau antibody for the treatment of Alzheimer's disease has reached Phase II, prompting…
November 2, 2017 - 2 minutes
German Biotech Unveils Positive Phase II Results for Alzheimer’s
Probiodrug has disclosed encouraging results of its latest Phase IIa trial to assess its lead…
June 12, 2017 - 3 minutes
Hopes are up: A Second Phase III Trial for Alzheimer’s Disease
The Swiss biotech AC Immune announced that its partner Genentech (Roche) will start a second phase…
February 28, 2017 - 3 minutes
